Back to Trades
Total Value
$351.6K
Net $351.6K sold
Filing Date
Jun 18, 2026
2 transactions
Sales
$351.6K
2 transactions
Trade Summary
On Jun 17, 2026 through Jun 18, 2026, Bodenstedt Matthias, Chief Financial Officer, sold $351.6K of MoonLake Immunotherapeutics (MLTX) across 2 transactions. The filing covers Class A ordinary shares, par value $0.0001 per share and reflects net selling of $351.6K. Reported prices ranged from $19.60 to $19.68. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- MoonLake Immunotherapeutics
- Ticker Symbol
- MLTX
- CIK
- 0001821586
Insider Information
- Role
- Chief Financial Officer
Filing Details
- Filing Date
- Jun 18, 2026
- Transaction Date
- Jun 17, 2026
- Accession Number
- 0001213900-26-070259
- Form Type
- 4
- Net Trading Amount
- -$351.6K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jun 17, 2026 | Class A ordinary shares, par value $0.0001 per share | 15,082 | $19.68 | Sale | $296.8K |
| Jun 18, 2026 | Class A ordinary shares, par value $0.0001 per share | 2,794 | $19.60 | Sale | $54.8K |
Want live alerts when Bodenstedt Matthias trades again?
Download Insider Trades to track MLTX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
- (F2)The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $19.50 to $20.06. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- (F3)The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $19.505 to $19.70. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.